Infectious Diseases: When the "Invisible Enemy" Strikes, Getein Helps You Fight

I. Introduction

Infectious diseases, humanity's oldest health threat, still claim over 13 million lives globally each year. Behind seemingly ordinary symptoms like cough and fever often lies a hidden battle between immune defenses and pathogens. In this constant struggle, accurate diagnosis becomes the decisive first step. Our advanced detection technologies provide that critical advantage.

II. Understanding the "Stealthy Invaders"

Infectious diseases are illnesses caused by various pathogens that can spread between humans, between animals, between humans and animals, or from the environment to humans. Common pathogens include: Viruses, Bacteria, Fungi, Parasites.

These "stealthy invaders" spread through respiratory, digestive, blood, or contact routes. Early identification of their "identity" is the prerequisite for effectively controlling outbreaks and enabling individualized treatment.

III. Getein's Precision Diagnostic Solutions

We provide comprehensive diagnostic solutions designed to meet the evolving challenges in infectious disease detection across clinical settings.

1. Viral Hepatitis Series

•Hepatitis B： This assay simultaneously detects five HBV markers to determine infection status, assess infectivity, and evaluate immune response. It provides a complete profile to guide clinical management and vaccination strategies.

•Anti-HCV: A high-sensitivity screening tool for detecting hepatitis C antibodies. It serves as the critical first step in identifying HCV exposure, enabling linkage to confirmatory testing and early intervention.

2. Major Infectious Disease Control

•HIV Ag/Ab: Our test shortens the diagnostic window by simultaneously detecting HIV antibodies and antigen. This allows for earlier and more reliable screening, which is crucial for timely treatment initiation.

•Anti-TP: This specific treponemal antibody test is essential for syphilis screening. It helps in the early diagnosis and, when used with non-treponemal tests, monitors treatment response and disease activity.

3. Gastrointestinal Infection Diagnosis

•H. pylori Antibody/Antigen: The antibody test aids in epidemiological screening, while the stool antigen test provides a direct, reliable method for diagnosing active infection and confirming eradication after therapy.

4. Respiratory Infection Testing

•SARS-CoV-2 Antigen: This rapid test is ideal for point-of-care and community-based screening of COVID-19. It facilitates quick triage and helps control transmission.

•CP/MP/ADV: This multiplex assay differentiates between Mycoplasma pneumoniae, Chlamydia pneumoniae, and Adenovirus. Accurate pathogen identification supports appropriate antibiotic use and targeted patient management.

•Influenza A/B: This rapid test distinguishes between Influenza A and B viruses at the point of care. It guides the use of specific antiviral medications and aids in outbreak surveillance.

5. Arboviral Disease Diagnosis

•Dengue IgG/IgM & NS1 Ag: Our combined approach enables comprehensive dengue diagnosis. The NS1 antigen test allows for early detection, while antibody testing helps determine the infection phase and immune status.

6. Pediatric Infection Testing

•EV/CA16/EV71: Specifically designed for pediatric enteroviral infections, this test detects common causes of hand-foot-mouth disease. It is particularly valuable for identifying EV71, which is associated with a higher risk of severe neurological complications.

7. Sexually Transmitted Infection Testing

•HPV: This test identifies high-risk and low-risk HPV genotypes. It is a fundamental tool for assessing cervical cancer risk, guiding vaccination programs, and informing screening protocols.

•CT/NG/UU: Offering a complete STI screening solution, this test simultaneously detects N. gonorrhoeae, C. trachomatis, and U. urealyticum from a single sample. It supports efficient diagnosis and treatment to prevent complications and transmission.

8. Chronic Disease Management

•MTB: Utilizing advanced molecular technology, this test rapidly detects M. tuberculosis complex DNA and associated rifampicin resistance. It significantly shortens turnaround time compared to culture, enabling faster treatment decisions for tuberculosis.

IV Getein's Solutions for Infectious Disease

POCT Platform

CLIA Platform

Molecular Diagnostics Platform